Cargando…
Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke
Background: Effects of YKL-40 on one-year clinical outcomes including poor clinical outcome, all-cause mortality, and stroke recurrence among acute ischemic stroke (AIS) patients remained elusive. The purpose of this study was to explore the association between serum YKL-40 at admission and one-year...
Autores principales: | Shi, Guomei, Li, Minghao, E, Yan, Wang, Meng, Gong, Pengyu, Wang, Xiaorong, Lu, Jingye, Wu, Weixiang, Xue, Shouru, Zhou, Junshan, Zhou, Rujuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008488/ https://www.ncbi.nlm.nih.gov/pubmed/36880855 http://dx.doi.org/10.18632/aging.204553 |
Ejemplares similares
-
The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
por: Shi, Guomei, et al.
Publicado: (2021) -
Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke
por: Shi, Guomei, et al.
Publicado: (2023) -
Correlation Between Cognitive Impairment and Homocysteine and S100B Protein in Patients with Progressive Ischemic Stroke
por: Li, Yan, et al.
Publicado: (2023) -
Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999) -
Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients
por: Park, Hyun Young, et al.
Publicado: (2012)